Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-27
2007-03-27
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S336000, C514S619000, C514S327000, C514S346000, C514S282000, C546S193000, C546S194000, C546S221000, C546S280400, C546S291000, C564S167000
Reexamination Certificate
active
10581164
ABSTRACT:
A compound of the formula (I) wherein the variables X1to X5, R1to R7including R3′, E, q, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed
REFERENCES:
patent: 2005/0182040 (2005-08-01), Imazaki et al.
patent: 1 072 592 (2001-01-01), None
patent: 2004/002367 (2004-01-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 01/46174 (2001-06-01), None
patent: WO 01/74806 (2001-10-01), None
patent: WO 02/48122 (2002-06-01), None
patent: WO 03/029233 (2003-04-01), None
patent: WO 2004/026305 (2004-04-01), None
patent: WO 2004/037800 (2004-05-01), None
patent: WO 2004/080968 (2004-09-01), None
patent: WO 2004/080996 (2004-09-01), None
Hcaplus 136:325560.
Benesh Dana Rae
Blanco-Pillado Maria-Jesus
Demeter John C.
Dentz Bernard
Eli Lilly and Company
Ginah Francis O.
Robinson Binta
LandOfFree
Opioid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opioid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3799861